体脂肪分布和左心房逆转改造,在导管切除以治疗心房之后
Kazutoshi Hirose1, Koki Nakanishi1,2, Masao Daimon1
1Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
JACC. Advances
|June 28, 2024
概括
即使在非肥胖患者中,中心脂肪也会阻碍导管切除后的左心房反向重塑. 评估身体脂肪分布对于预测心房患者的结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 医学研究 医学研究
- 肥胖研究 肥胖研究
背景情况:
- 肥胖与心房 (AF) 有关,但其对非肥胖心房患者左心房 (LA) 重塑的影响尚不清楚.
- 身体脂肪分布在LA重塑中的作用及其可逆性需要进一步研究.
研究的目的:
- 检查身体脂肪分布和LA大小之间的关联.
- 为了研究体脂肪分布对管切除 (CA) 后LA逆重塑 (LARR) 的影响.
主要方法:
- 116名接受首次CA的非肥胖AF患者的身体脂肪百分比 (BF%) 和中心脂肪百分比 (CF%) 被评估.
- 患者根据身体质量指数 (BMI),腰与部 (W/H) 比率,BF%和CF%进行分类.
- 在CA之前和6个月后的心声学评估了LA大小和LARR,使用多变量逻辑回归.
主要成果:
- 无论是体型指标还是脂肪度量都与基线LA大小无关.
- 较高的W/H比率和CF%与CA后6个月持续的LA扩大有关 (P<0.01).
- W/H比率和CF%独立地预测了缺乏LARR (调整后的OR分别为3.86和2.81;P<0.01).
结论:
- 中枢脂肪性与非肥胖的AF患者中CA之后的LARR缺乏相关.
- 身体脂肪的分布,特别是中心脂肪,是预测LA重塑结果的重要因素.
- 评估身体脂肪分布对于在非肥胖的AF患者中进行CA的风险分层至关重要.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
1.7K
相关概念视频
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
